StockData
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc. (BOLT) stock

BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/305% above fair value
$5.65−0.15 (-2.59%)

Close on Nov 17, 2026Market cap $10.88MP/E –Yield –

Bolt Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bolt Biotherapeutics's market cap was $12.06M on Nov 11, 2026, against $9.73M a year earlier. Over the last 5 years it ranged from $7.09M to $182.52M, with a median of $28.85M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$12.06M+14.9%
2025Dec 31, 2025$10.50M-48.8%
2024Dec 31, 2024$20.48M-51.8%
2023Dec 29, 2023$42.52M-13.1%
2022Dec 30, 2022$48.96M-73.2%
2021Dec 31, 2021$182.52M–

More Bolt Biotherapeutics figures

See a number that looks wrong?